RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

TE7 ACE (Ultrasonography scanner)

Product
Developers: Mindray Medical International
Date of the premiere of the system: March, 2020
Branches: Pharmaceutics, medicine, health care

2020: Announcement

At the beginning of March, 2020 Mindray Medical company provided a new ultrasonic system for care of patients of TE7 ACE. This new ultrasonography scanner uses deep learning and provides versatile solutions for different scenarios of delivery of health care, including anesthesia, intensive therapy and emergency aid.

The TE7 ACE scanner equipped with intelligent tools for management of infusional therapy, tools for safe sampling and the complete solution for disinfection helps doctors to solve diagnostic problems and to quickly make decisions, kasayuashchiyesya therapies.

Mindray Medical provided a new ultrasonic system for care of patients of TE7 ACE

Fast assessment allows to develop the plan of infusional therapy and to save life in emergency situation. A system uses the advanced intsrument on the basis of algorithms of deep learning for exact and effective assessment of patients. A system automatically calculates warm emission and change of shock volume, helps to estimate volume loading and speed of reaction of vessels. The Smart B-line tool provides the unique visual card of assessment for overall assessment of stagnation of blood, controlling infusion of liquid and preventing a pulmonary edema.

To provide safe, simple and convenient introduction of a needle, the scanner integrates recently released L12-3VN system with eSpacial NaviTM and the remote control so doctors can execute a puncture, without concerning a system.

The solution for connection of eGateway also allows the TE7 ACE system to fit freely into the existing hospital network and to integrate the clinical data of the patient received both from the ultrasonography equipment, and from the systems of a monitorovaniye of patients. This effective processing of electronic data increases performance and at the same time sniat risk of errors of a transcription, increasing reliability at adoption of clinical solutions.[1]

Notes